Showing results (731-740 of 835) with videos related to

Sort By:
Pageof 84
Blood|June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphomaJakub Svoboda, Susan R Rheingold, Saar I Gill, et al.
Cancer Immunology Research|July 22, 2018
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T CellsSaba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Pediatric Blood & Cancer|May 24, 2021
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group studyBrian D Weiss, Gregory Yanik, Arlene Naranjo, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
Blood|June 21, 2024
Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescentsCaroline Diorio, Laura Hernandez-Miyares, Diego A Espinoza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2011
Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group studyAndrew L Gilman, Kirk R Schultz, Frederick D Goldman, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
Nature Genetics|December 9, 2014
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrenceLei Gu, Sandra C Frommel, Christopher C Oakes, et al.
Pageof 84